Dr. David Kattan, MD

Dr. Kattan practices at Southern California Hospital at Hollywood in Hollywood, California, part of Healthcare Systems of America.

Dr. Kattan's NPI, 1104873249, was assigned on May 27, 2006. Dr. Kattan graduated from New York Medical College in 1989. Dr. Kattan holds California license G69002.

Dr. Kattan's primary practice is Southern California Hospital at Hollywood, at 6245 De Longpre Ave, Hollywood, CA 90028 in Los Angeles County. The practice phone is (323) 462-2271.

Dr. Kattan's primary practice is Southern California Hospital at Hollywood in Hollywood, California, part of Healthcare Systems of America. Dr. Kattan is also affiliated with Cedars-Sinai Medical Center. Dmand AI also links Dr. Kattan to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kattan practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kattan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kattan is licensed in California.

Dmand AI lists aneurysm, aortic atherosclerois, atherosclerosis, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy and cerebrovascular disease among the conditions Dr. Kattan treats.

CMS data shows 15,651 Medicare services from Dr. Kattan across 33 procedure codes in 2024, for 968 Medicare patients. Medicare paid $1,094,516 for them.

CMS counts 968 Medicare patients who saw Dr. Kattan in 2024. The largest group is 65 to 74, with 331 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 75% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kattan's median patient age at 72, with 52% women.

In 2024, Dr. Kattan wrote 7,368 Medicare Part D claims for 363 patients. 85% of them were for generic drugs. CMS names the drug for 6,696 of them, across 140 drugs with 11 or more claims each, at $813,397 in total drug cost. In 2023, CMS named 5,878 claims across 129 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kattan for performance year 2024, reported individually. Dr. Kattan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kattan as offering telehealth.

CMS Open Payments shows 133 general payments to Dr. Kattan from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Medtronic, Inc. paid the most, $538.

Dr. Kattan graduated from New York Medical College in 1989.

Dr. Kattan is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.